Medindia
Medindia LOGIN REGISTER
Advertisement

Boston Scientific Announces FDA Approval and U.S. Launch of PROMUS® 2.25 mm Everolimus-Eluting Coronary Stent System

Wednesday, May 25, 2011 General News
Advertisement
Boston Scientific becomes the first and only company to offer two distinct drug-eluting stents to treat small vessels

CONTACT:

Erik Kopp

508-650-8660 (office)

Media Relations

Boston Scientific Corporation

[email protected]

Sean Wirtjes

508-652-5305 (office)

Investor Relations

Boston Scientific Corporation

[email protected]

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close